Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine effects on hypoxic ventilatory response
ISRCTN42617929Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esketamine (3 arms), sponsored by Leiden University Medical Center. Primary endpoint: Hypoxic ventilatory response. Started Jul 2023; status: completed.
02
Drugs
esketamine
Beyond the preview
Go deeper on ISRCTN42617929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN42617929.